CXCR4 and WHIM syndrome: Our previous studies support this argument, demonstrating that the CXCR4 antagonist effectively mobilizes neutrophils while preserving their effector functions in a mouse model of WHIM syndrome as well as in patients with chronic neutropenia (34, 38).